Search
Alcon AG
ALCAdd to Watchlist
67.830USD
-0.300-0.44%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
33.06BMarket Cap
40.66P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-0.44%
5 Days
+4.87%
1 Month
+0.19%
6 Months
-15.61%
Year to Date
-13.93%
1 Year
-22.13%
Key Figures
67.880Open
68.460High
1.49MVolume
40.66P/E TTM
17.24P/E Dynamic
0.249Dividend TTM
0.30%Turnover Ratio
68.130Prev. Close
67.440Low
54.94MTurnover
32.48P/E Static
1.50P/B
0.37%Div Yield TTM
2.62%ROA
74.34052wk High
0.84Volume Ratio
1.02BNet Profit
487.40MShares
1.6680EPS TTM
1.01Beta
3.71%ROE
47.80052wk Low
1.50%Amplitude
61.83%Gross Margin
33.06BMarket Cap
3.20Reward/Risk
1.17%Risk Rate
TradingKey Stock Score of Alcon AG
Currency: USD Updated: 2026-06-26Key Insights
Alcon AG's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 31 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 87.94.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Alcon AG's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Alcon AG Highlights
StrengthsRisks
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 15.23%.
Fairly Valued
The company’s latest PE is 40.65, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 347.13M shares, decreasing 4.55% quarter-over-quarter.
Analyst Rating
Based on
18
analysts
Buy
Current Rating
87.940
Target Price
+29.08%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Alcon AG News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Alcon AG Info
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
Ticker SymbolALC
CompanyAlcon AG
CEOEndicott (David J)
Websitehttps://www.alcon.ch/
Related Instruments
+2.87%
+1.47%
+0.64%
+1.25%
+1.31%
-0.32%
+5.22%
+0.56%
+1.16%
+2.06%
+0.18%
-0.14%
-0.27%
+1.18%
+2.09%
+3.03%
-0.62%
+0.32%
-0.71%
+0.45%Popular Instruments
51752.200
-272.500 (-0.52%)
28987.500
-467.500 (-1.59%)
7332.000
-34.800 (-0.47%)
15282.000
-469.000 (-2.98%)
69508.000
-1624.000 (-2.28%)
6207.100
-58.700 (-0.94%)
70.148
-1.196 (-1.68%)
283.780
+8.630 (+3.14%)
192.530
-3.210 (-1.64%)
4087.760
+61.610 (+1.53%)
FAQs
What is the current price of Alcon AG (ALC)?
The current price of Alcon AG (ALC) is 67.83.
What is the symbol of Alcon AG?
The ticker symbol of Alcon AG is ALC.
What is the 52-week high of Alcon AG?
The 52-week high of Alcon AG is 74.34.
What is the 52-week low of Alcon AG?
The 52-week low of Alcon AG is 47.80.
What is the market capitalization of Alcon AG?
The market capitalization of Alcon AG is 33.06B.
Is Alcon AG (ALC) currently rated as Buy, Hold, or Sell?
According to analysts, Alcon AG (ALC) has an overall rating of Buy, with a price target of 87.94.
What is the Earnings Per Share (EPS TTM) of Alcon AG (ALC)?
The Earnings Per Share (EPS TTM) of Alcon AG (ALC) is 1.99.
